Florence DUFFAUD
La TIMONE University Hospital · Hôpital de la Timone (MARSEILLE) · La Timone University Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Florence DUFFAUD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 20:51 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06524583 · Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the TumourUNICANCER · recruiting · Leiomyosarcoma Uterus · principal investigator
- N/ANCT04055220 · Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone SarcomasCentre Leon Berard · recruiting · Bone Sarcoma, Osteosarcoma, Ewing Sarcoma · principal investigator
- Ph2NCT02389244 · A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone SarcomasUNICANCER · completed · Ewing Sarcomas, Chondrosarcomas, Osteosarcomas · principal investigator
- Ph2NCT00227669 · Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue LeiomyosarcomaUNICANCER · completed · Sarcoma · study chair
- Ph2NCT00022594 · Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck CancerEuropean Organisation for Research and Treatment of Cancer - EORTC · completed · Head and Neck Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-11 20:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 20:51 UTC. The ranking covers the 200 most relevant of 52 PubMed records, and a shared surname and initials can bring in a namesake. All 52 on PubMed
- 304 citationsRCR 7.3
- Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial.Lancet Oncol · 2020276 citationsRCR 13.1
- Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study.Lancet Oncol · 2019273 citationsRCR 10.7
- Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial.Lancet Oncol · 2010228 citationsRCR 4.6
- 176 citationsRCR 5.3
- 172 citationsRCR 5.4
- Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis.Acta Oncol · 2017161 citationsRCR 6.7
- 136 citationsRCR 4.6
- 117 citationsRCR 9.6
- Impact of the prophylactic gastrostomy for unresectable squamous cell head and neck carcinomas treated with radio-chemotherapy on quality of life: Prospective randomized trial.Radiother Oncol · 2009106 citationsRCR 3.8